Open access · OA via Europe PMC

Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review

Cozma D, Tudoran C, Vacarescu C.

Current issues in molecular biology · 2026

Stem-cell exhaustion Intermittent fasting Metformin Review

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: Europe PMC
Canonical: link ↗
Fetched: 2026-10-28 MST

Cite this

APA

D, C., C, T., & C., V. (2026). Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review. <em>Current issues in molecular biology</em>. https://europepmc.org/article/PMC/PMC13703335

Vancouver

D C, C T, C. V. Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review. Current issues in molecular biology. 2026.

BibTeX

@article{cozma2026Metfor, title = {Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review}, author = {Cozma D and Tudoran C and Vacarescu C.}, journal = {Current issues in molecular biology}, year = {2026}, }